216 related articles for article (PubMed ID: 21212796)
21. Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs.
Das S; Bryan K; Buckley PG; Piskareva O; Bray IM; Foley N; Ryan J; Lynch J; Creevey L; Fay J; Prenter S; Koster J; van Sluis P; Versteeg R; Eggert A; Schulte JH; Schramm A; Mestdagh P; Vandesompele J; Speleman F; Stallings RL
Oncogene; 2013 Jun; 32(24):2927-36. PubMed ID: 22797059
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA mediates DNA demethylation events triggered by retinoic acid during neuroblastoma cell differentiation.
Das S; Foley N; Bryan K; Watters KM; Bray I; Murphy DM; Buckley PG; Stallings RL
Cancer Res; 2010 Oct; 70(20):7874-81. PubMed ID: 20841484
[TBL] [Abstract][Full Text] [Related]
23. MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.
Haug BH; Henriksen JR; Buechner J; Geerts D; Tømte E; Kogner P; Martinsson T; Flægstad T; Sveinbjørnsson B; Einvik C
Carcinogenesis; 2011 Jul; 32(7):1005-12. PubMed ID: 21572098
[TBL] [Abstract][Full Text] [Related]
24. Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line.
Chevrier L; Meunier AC; Cochaud S; Muller JM; Chadéneau C
Int J Oncol; 2008 Nov; 33(5):1081-9. PubMed ID: 18949372
[TBL] [Abstract][Full Text] [Related]
25. MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells.
Kang JH; Rychahou PG; Ishola TA; Qiao J; Evers BM; Chung DH
Biochem Biophys Res Commun; 2006 Dec; 351(1):192-7. PubMed ID: 17055458
[TBL] [Abstract][Full Text] [Related]
26. miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma.
Chava S; Reynolds CP; Pathania AS; Gorantla S; Poluektova LY; Coulter DW; Gupta SC; Pandey MK; Challagundla KB
Mol Oncol; 2020 Jan; 14(1):180-196. PubMed ID: 31637848
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of cyclin-dependent kinase 1-induced cell death in neuroblastoma cells through the microRNA-34a-MYCN-survivin pathway.
Chen Y; Tsai YH; Tseng SH
Surgery; 2013 Jan; 153(1):4-16. PubMed ID: 22703967
[TBL] [Abstract][Full Text] [Related]
28. Silencing of MYCN by RNA interference induces growth inhibition, apoptotic activity and cell differentiation in a neuroblastoma cell line with MYCN amplification.
Nara K; Kusafuka T; Yoneda A; Oue T; Sangkhathat S; Fukuzawa M
Int J Oncol; 2007 May; 30(5):1189-96. PubMed ID: 17390021
[TBL] [Abstract][Full Text] [Related]
29. Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastoma.
De Brouwer S; Mestdagh P; Lambertz I; Pattyn F; De Paepe A; Westermann F; Schroeder C; Schulte JH; Schramm A; De Preter K; Vandesompele J; Speleman F
Int J Cancer; 2012 Jun; 130(11):2591-8. PubMed ID: 21796614
[TBL] [Abstract][Full Text] [Related]
30. Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma Patients.
Ribeiro D; Klarqvist MDR; Westermark UK; Oliynyk G; Dzieran J; Kock A; Savatier Banares C; Hertwig F; Johnsen JI; Fischer M; Kogner P; Lovén J; Arsenian Henriksson M
Cell Rep; 2016 Jul; 16(4):979-993. PubMed ID: 27396325
[TBL] [Abstract][Full Text] [Related]
31. Expression and DNA-binding activity of MYCN/Max and Mnt/Max during induced differentiation of human neuroblastoma cells.
Smith AG; Popov N; Imreh M; Axelson H; Henriksson M
J Cell Biochem; 2004 Aug; 92(6):1282-95. PubMed ID: 15258910
[TBL] [Abstract][Full Text] [Related]
32. A new module in neural differentiation control: two microRNAs upregulated by retinoic acid, miR-9 and -103, target the differentiation inhibitor ID2.
Annibali D; Gioia U; Savino M; Laneve P; Caffarelli E; Nasi S
PLoS One; 2012; 7(7):e40269. PubMed ID: 22848373
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of XAB2 enhances all-trans retinoic acid-induced cellular differentiation in all-trans retinoic acid-sensitive and -resistant cancer cells.
Ohnuma-Ishikawa K; Morio T; Yamada T; Sugawara Y; Ono M; Nagasawa M; Yasuda A; Morimoto C; Ohnuma K; Dang NH; Hosoi H; Verdin E; Mizutani S
Cancer Res; 2007 Feb; 67(3):1019-29. PubMed ID: 17283134
[TBL] [Abstract][Full Text] [Related]
34. Expressional alterations in functional ultra-conserved non-coding RNAs in response to all-trans retinoic acid--induced differentiation in neuroblastoma cells.
Watters KM; Bryan K; Foley NH; Meehan M; Stallings RL
BMC Cancer; 2013 Apr; 13():184. PubMed ID: 23565812
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-184 downregulates nuclear receptor corepressor 2 in mouse spermatogenesis.
Wu J; Bao J; Wang L; Hu Y; Xu C
BMC Dev Biol; 2011 Oct; 11():64. PubMed ID: 22017809
[TBL] [Abstract][Full Text] [Related]
36. Use of RNA interference to elucidate the effect of MYCN on cell cycle in neuroblastoma.
Woo CW; Tan F; Cassano H; Lee J; Lee KC; Thiele CJ
Pediatr Blood Cancer; 2008 Feb; 50(2):208-12. PubMed ID: 17420990
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid.
Khan S; Wall D; Curran C; Newell J; Kerin MJ; Dwyer RM
BMC Cancer; 2015 May; 15():345. PubMed ID: 25934412
[TBL] [Abstract][Full Text] [Related]
38. Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastoma.
Schramm A; Köster J; Marschall T; Martin M; Schwermer M; Fielitz K; Büchel G; Barann M; Esser D; Rosenstiel P; Rahmann S; Eggert A; Schulte JH
Int J Cancer; 2013 Feb; 132(3):E106-15. PubMed ID: 22907398
[TBL] [Abstract][Full Text] [Related]
39. MYCN regulates oncogenic MicroRNAs in neuroblastoma.
Schulte JH; Horn S; Otto T; Samans B; Heukamp LC; Eilers UC; Krause M; Astrahantseff K; Klein-Hitpass L; Buettner R; Schramm A; Christiansen H; Eilers M; Eggert A; Berwanger B
Int J Cancer; 2008 Feb; 122(3):699-704. PubMed ID: 17943719
[TBL] [Abstract][Full Text] [Related]
40. Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas.
Chayka O; Corvetta D; Dews M; Caccamo AE; Piotrowska I; Santilli G; Gibson S; Sebire NJ; Himoudi N; Hogarty MD; Anderson J; Bettuzzi S; Thomas-Tikhonenko A; Sala A
J Natl Cancer Inst; 2009 May; 101(9):663-77. PubMed ID: 19401549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]